A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration
Jason Chiang(St. Jude Children's Research Hospital), David W. Ellison(Drug Discovery Laboratory (Norway)), Christopher L. Tinkle(St. Jude Children's Research Hospital), Ibrahim Qaddoumi(St. Jude Children's Research Hospital), Sahaja Acharya(Johns Hopkins University), Daniel C. Moreira(St. Jude Children's Research Hospital), Xiaoyu Li(Capital University), Julie H. Harreld(Harvard University)
Cited by 88
Related Papers
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853
Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease
|Journal of Clinical Oncology|2010|657
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas
|Cancer Cell|2020|470
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
|Journal of Clinical Oncology|2017|345
The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200–dependent pathway in mice
|Journal of Clinical Investigation|2011|197